Welcome to our dedicated page for Bowhead Specialty Holdings SEC filings (Ticker: BOW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Bowhead Specialty Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Bowhead Specialty Holdings's regulatory disclosures and financial reporting.
Bowhead Specialty Holdings Inc. Chief Accounting Officer Shirley Shek Li Yap surrendered 2,353 shares of common stock at $28.30 per share to cover tax withholdings due on vesting of restricted stock units. After this non-market, tax-related disposition, she directly holds 81,205 shares of Bowhead common stock.
Bowhead Specialty Holdings Inc. reported a routine insider tax-withholding transaction by its CFO and Treasurer, Brad Mulcahey. On May 23, 2026, he surrendered 3,506 shares of common stock at $28.30 per share to cover required tax withholdings upon vesting of restricted stock units. After this non-market disposition, he directly holds 132,821 shares of Bowhead Specialty common stock.
Bowhead Specialty Holdings Inc. Chief Underwriting Officer David John Newman surrendered 4,506 shares of common stock to the company at $28.30 per share to cover required tax withholdings on vested restricted stock units. This was a tax-withholding disposition rather than an open-market sale. After the transaction, he directly holds 292,689 shares of Bowhead common stock.
Bowhead Specialty Holdings Inc. CEO and President Stephen Jay Sills reported a routine tax-withholding event related to equity compensation. He surrendered 24,353 shares of common stock at $28.46 per share to cover required tax withholdings upon vesting of restricted stock units, leaving 838,926 shares held directly plus additional indirect holdings through various trusts and an LLC.
Bowhead Specialty Holdings Inc. reported solid first-quarter 2026 growth, with total revenues of $155,694 thousand, up 26.9% from the prior-year period. Net earned premiums rose 24.6% to $136,808 thousand, driven by 24.0% gross written premium growth across all four underwriting divisions, led by Casualty and Baleen Specialty.
Net income increased 40.1% to $16,010 thousand, and diluted earnings per share reached $0.48. The combined ratio improved to 95.3% from 97.3%, as the expense ratio fell 2.0 points while the loss ratio held steady at 66.9%, reflecting disciplined underwriting.
Net investment income grew 43.5% to $18,027 thousand on a larger fixed-maturity portfolio, although unrealized losses on investments reduced accumulated other comprehensive income. Return on equity rose to 14.1%, supported by stronger underwriting income and higher investment returns, while the company maintained reinsurance with highly rated counterparties and remained in compliance with debt and credit facility covenants.
Bowhead Specialty Holdings Inc. reported strong first-quarter 2026 results and amended key reinsurance arrangements with American Family Mutual Insurance Company. Gross written premiums rose 24.0% to $216.7 million, while net income increased 40.1% to $16.0 million, or $0.48 per diluted share. Total revenues grew 26.9% to $155.7 million, and the combined ratio improved to 95.3%, driven by a stable loss ratio of 66.9% and a lower expense ratio of 28.4%.
Return on equity reached 14.1%, with adjusted net income of $16.0 million. Gross written premiums grew across all divisions, including Baleen Specialty, which climbed 313.9% to $11.4 million, and digital business reaching $14.8 million. Net investment income rose 43.5% to $18.0 million on a largely investment‑grade portfolio yielding 4.6%. Amendments to the quota share and related trust agreements raised the premium threshold at which American Family can terminate the quota share from $1.0 billion to $1.5 billion, extended required termination notice from 180 to 365 days, and increased ceding commission and collateralization requirements over time.
Baker Tom reported acquisition or exercise transactions in this Form 4 filing.
Bowhead Specialty Holdings Inc. director Tom Baker received a grant of 3,361 shares of Common Stock in the form of restricted stock units on April 30, 2026. The award was recorded at a price of $0.00 per share, reflecting a compensation grant rather than an open-market purchase. After this grant, Baker directly holds a total of 10,085 shares of the company’s common stock.
Bowhead Specialty Holdings Inc. director Angela Brock-Kyle received an equity grant of 6,722 shares of Common Stock in the form of restricted stock units on April 30, 2026. The award was recorded at a price of $0.00 per share as a compensation grant, not a market purchase.
Following this grant, Brock-Kyle directly holds a total of 43,495 shares of Bowhead Specialty Holdings Inc. common stock. The filing classifies the transaction as a grant or award acquisition, highlighting ongoing stock-based compensation for the company’s board.
Bowhead Specialty Holdings Inc. director David Thomas Foy received a grant of 3,361 shares of Common Stock in the form of restricted stock units on April 30, 2026. The award carried a stated price of $0.00 per share, consistent with a compensation grant rather than a market purchase.
After this award, Foy directly owns 10,085 shares of Bowhead Specialty Holdings common stock. The filing characterizes the transaction as a grant or other acquisition, reflecting routine equity-based director compensation rather than an open-market trade.
Fondriest Fabian reported acquisition or exercise transactions in this Form 4 filing.
Bowhead Specialty Holdings Inc. director Fabian Fondriest received a grant of 6,722 shares of Common Stock in the form of restricted stock units. The award, dated April 30, 2026, was issued at no cash cost and increased his direct holdings to 49,818 shares.